LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 54.27 | 17.25 | 1319 | 4884 | 0.2701 | 0.7031 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.24 | 17.25 | 1057 | 4929 | 0.2144 | 0.6560 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.24 | 17.25 | 1078 | 4929 | 0.2187 | 0.6600 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.24 | 17.25 | 5 | 4929 | 0.0010 | -0.1408 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 56.24 | 17.25 | 1324 | 4929 | 0.2686 | 0.7024 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 17.25 | 1060 | 4942 | 0.2145 | 0.6562 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 17.25 | 1078 | 4942 | 0.2181 | 0.6596 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 17.25 | 6 | 4942 | 0.0012 | -0.1214 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 17.25 | 1282 | 4942 | 0.2594 | 0.6952 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.18 | 17.25 | 1067 | 5031 | 0.2121 | 0.6549 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.18 | 17.25 | 1088 | 5031 | 0.2162 | 0.6589 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.18 | 17.25 | 5 | 5031 | 0.0010 | -0.1404 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.18 | 17.25 | 1304 | 5031 | 0.2592 | 0.6959 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.15 | 17.25 | 1077 | 5061 | 0.2128 | 0.6559 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.15 | 17.25 | 1096 | 5061 | 0.2166 | 0.6595 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.15 | 17.25 | 6 | 5061 | 0.0012 | -0.1209 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 63.15 | 17.25 | 1307 | 5061 | 0.2583 | 0.6955 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.12 | 17.25 | 1078 | 5095 | 0.2116 | 0.6551 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.12 | 17.25 | 1088 | 5095 | 0.2135 | 0.6570 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.12 | 17.25 | 4 | 5095 | 0.0008 | -0.1632 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 65.12 | 17.25 | 1262 | 5095 | 0.2477 | 0.6872 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.09 | 17.25 | 1074 | 5221 | 0.2057 | 0.6508 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.09 | 17.25 | 1090 | 5221 | 0.2088 | 0.6538 | MN20160310_N02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.09 | 17.25 | 4 | 5221 | 0.0008 | -0.1625 | MN20160310_N02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.09 | 17.25 | 1316 | 5221 | 0.2521 | 0.6920 | MN20160310_N02 | J22 |